Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15112281

Cancer 2004 May 1 100 9 1987-8; author reply 1988

Download in:

View as

Triples

General Info

PMID
15112281